Equity
€951,930 from €5.9m in 2021
Equity fell by 84% in 5 years.
STERIS
Lifetime
19 annual accounts with figures on one time axis, 37 filings since 1990peak €17.9m (2026)
€17.9m▲ 27.5%
peak €637,621 (2023)
€616,297▲ 22.1%
peak €5.9m (2021)
€951,930▼ 37.2%
€15.2m▲ 30.1%
peak 20.5 FTE (2026)
20.5 FTE▲ 26.5%
Board10 names since 2005
3 directors and 2 others
Owners6 names in the annual accounts
99.99% and 2 others
Documentsfilings and deeds
09-11-20269 days late
2026financial year
Turnover from €14.1m to €17.9mStaff from 16.2 FTE to 20.5 FTEResignation: (director) 09-02Dividend €1.2mEquity from €1.5m to €951,930Debts from €11.7m to €15.2m
Key points
from the 2026 annual accountsDebts
€15.2m 94% of the balance sheet
Suppliers 48%Taxes and wages 7%Other 45%
Of this, €14.3m falls due within a year.
Filings
37 annual accounts since 1990
Five of the last ten came late. The 2017 accounts came latest: 198 days after the end of the period.
At the same address
302 companies
Board
1 joined · 1 left
Board changed. Latest change 08-12-2025 · 3 in office.
Position in the sector
5.9%
Lower solvency than 91% of companies in wholesale trade. Sector median 42.1% · 221 companies.
Checked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 1,220 companies had the same profile as STERIS has now. Each dot stands for 4 companies, two years later.
95.9%
were still trading
2.5%
stopped another way
1.5%
went bankrupt
Test of the method
The method was tested on the 497,762 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 1,220 companies, not a prediction for STERIS. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Board and ownership
Director, since 27-10-2022
Director, since 09-09-2024
Director, since 08-12-2025
Auditor,
- 99.99%annual accounts 31-03-2026
- consolidatesannual accounts 31-03-2026
- 0.01%annual accounts 31-03-2026
Recent changes
Resignation: (director)
Appointment: (director) · General meeting of 08-12-2025 · Gazette deed
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0440556578
1 director appointed, 1 resignation, 1 reappointment
Resignation: · Reappointment: · Appointment: · General meeting of 26-09-2024 · Gazette deed
Permanent representative:
Reappointment: (statutory auditor) · General meeting of 30-11-2023 · Gazette deed
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| STERIS Watermael-Boitsfort | €17.9m | 4.8% | 5.9% | 20.5 |
| S.A Therabel-Pharma N.V. Forest | €15.7m | -28.9% | 32.2% | 28.3 |
| INTERNATIONAL MEDICAL PRODUCTS Sint-Gillis (bij-Brussel) | €23.8m | 3.7% | 41.3% | 16.3 |
| DE CEUNYNCK MEDICAL Aartselaar | €14.4m | 2.1% | 84.3% | 21.3 |
| METROHM BELGIUM Kontich | €14.3m | 7.1% | 64.8% | 29.5 |
| BeMedico Herzele | €17.4m | 8.1% | 66.2% | 14.6 |
| FertiPro Beernem | €13.3m | 7.7% | 51.8% | 29.4 |
Grey: the largest companies of the sector (wholesale trade (NACE 46)), without their names. Blue: the sector peers from the table.
These companies have the same main activity as STERIS: wholesale of pharmaceutical and medical goods (NACE 46460). They are comparable in size and age: total assets between €10m and €17m, founded between 1980 and 1995.
Official details
Source: KBO- Status
- Active since 10-04-1990Normal situation
- Registered office
- 304 active companies are registered at this address24 started in the 12 months before. Source: KBO register, as of 15 November 2026.
- Activity
- Wholesale of pharmaceutical and medical goodsNACE 46460
- Establishment unit
- 2.048.091.0581170 Watermael-Boitsfort, since 02-05-1990
- Financial year end
- 31 March
- Peppol
- Reachable since 15-09-2025
Annual accounts to 31-03-2026
- €16.2m▲ 22.4%
- Employeeson 31-03-2026
- 21▲ 23.5%
- Filing
- Filed on 09-11-2026
Insights on STERIS
STERIS has existed since 1990. Turnover grew from €4.5m in 2007 to €17.9m in 2026 and staff from 7.3 to 20.5 full-time equivalents.
Solvency fell in 2026 from 11.5% to 5.9% because of the dividend and higher debts to suppliers.
holds all the shares.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about STERIS
- What is the company number of STERIS?
- The company number of STERIS is 0440.556.578. The VAT number is the same number with BE in front: BE 0440.556.578.
- Where is STERIS based?
- The registered office is at Terhulpsesteenweg 177, 1170 Watermael-Boitsfort.Company details
- What does STERIS do?
- According to the KBO register, the main activity is wholesale of pharmaceutical and medical goods (NACE 46460).
- What is the legal form of STERIS?
- STERIS is a public limited company (NV).
- When was STERIS founded?
- STERIS was founded on 10-04-1990.
- Is STERIS still active?
- Yes, STERIS is an active enterprise in the KBO register.
- How many employees does STERIS have?
- STERIS had an average of 20.5 full-time equivalents in financial year 2026, according to the filed annual accounts.Financials
- What is the turnover of STERIS?
- The turnover of STERIS was €17.9m in financial year 2026, according to the filed annual accounts.
- Is STERIS profitable?
- In financial year 2026, STERIS made a profit of €616,297.
- Where can I find the annual accounts of STERIS?
- STERIS filed 37 annual accounts with the National Bank of Belgium, the latest for financial year 2026.
- When are the next annual accounts of STERIS due?
- STERIS must file the annual accounts for financial year 2027 by 31-10-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence See whether the workforce is growing and whether people stay.Employer check Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark
See how customers, suppliers and banks see your own company and what to improve first.